177 related articles for article (PubMed ID: 2142393)
1. Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors.
Grubbs CJ; Eto I; Juliana MM; Hardin JM; Whitaker LM
Anticancer Res; 1990; 10(3):661-6. PubMed ID: 2142393
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis by retinyl acetate.
Moon RC; Grubbs CJ; Sporn MB
Cancer Res; 1976 Jul; 36(7 PT 2):2626-30. PubMed ID: 819130
[TBL] [Abstract][Full Text] [Related]
3. Effect of retinyl acetate on the occurrence of ovarian hormone-responsive and -nonresponsive mammary cancers in the rat.
Thompson HJ; Meeker LD; Tagliaferro AR; Becci PJ
Cancer Res; 1982 Mar; 42(3):903-5. PubMed ID: 6800647
[TBL] [Abstract][Full Text] [Related]
4. Influence of dietary retinyl acetate on normal rat mammary gland development and on the enhancement of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by high levels of dietary fat.
Aylsworth CF; Cullum ME; Zile MH; Welsch CW
J Natl Cancer Inst; 1986 Feb; 76(2):339-45. PubMed ID: 3080638
[TBL] [Abstract][Full Text] [Related]
5. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat.
Moon RC; Thompson HJ; Becci PJ; Grubbs CJ; Gander RJ; Newton DL; Smith JM; Phillips SL; Henderson WR; Mullen LT; Brown CC; Sporn MB
Cancer Res; 1979 Apr; 39(4):1339-46. PubMed ID: 421218
[TBL] [Abstract][Full Text] [Related]
6. Retinoids as chemopreventive agents for breast cancer.
Moon RC; Mehta RG; Detrisac CJ
Cancer Detect Prev; 1992; 16(1):73-9. PubMed ID: 1551141
[TBL] [Abstract][Full Text] [Related]
7. Influence of delayed administration of retinyl acetate on mammary carcinogenesis.
McCormick DL; Moon RC
Cancer Res; 1982 Jul; 42(7):2639-43. PubMed ID: 7083156
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC
Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682
[TBL] [Abstract][Full Text] [Related]
9. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC
Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843
[TBL] [Abstract][Full Text] [Related]
10. Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors.
Silverman J; Katayama S; Radok P; Levenstein MJ; Weisburger JH
Nutr Cancer; 1983; 4(3):186-91. PubMed ID: 6221232
[TBL] [Abstract][Full Text] [Related]
11. Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model.
Rodríguez-Burford C; Lubet RA; Eto I; Juliana MM; Kelloff GJ; Grubbs CJ; Steele VE
Carcinogenesis; 1999 Jan; 20(1):71-6. PubMed ID: 9934852
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen.
Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
Anticancer Res; 1992; 12(4):1147-53. PubMed ID: 1386970
[TBL] [Abstract][Full Text] [Related]
13. Effect of moderate vitamin A supplementation and lack of dietary vitamin A on the development of mammary tumors in female rats treated with low carcinogenic dose levels of 7,12-dimethylbenz(a)anthracene.
Zile MH; Cullum ME; Roltsch IA; DeHoog JV; Welsch CW
Cancer Res; 1986 Jul; 46(7):3495-503. PubMed ID: 3085923
[TBL] [Abstract][Full Text] [Related]
14. Retinoid feeding, hormone inhibition, and/or immune stimulation and the progression of N-methyl-N-nitrosourea-induced rat mammary carcinoma: suppression by retinoids of peptide hormone-induced tumor cell proliferation in vivo and in vitro.
Welsch CW; DeHoog JV; Scieszka KM; Aylsworth CF
Cancer Res; 1984 Jan; 44(1):166-71. PubMed ID: 6360344
[TBL] [Abstract][Full Text] [Related]
15. Lack of an effect of dietary retinoids in chemical carcinogenesis of the mouse mammary gland: inverse relationship between mammary tumor cell anaplasia and retinoid efficacy.
Welsch CW; DeHoog JV; Moon RC
Carcinogenesis; 1984 Oct; 5(10):1301-4. PubMed ID: 6237806
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic variability of chemically induced primary rat mammary tumors.
Dolezalová V; Rejthar A; Sugár J; Tóth J; Vermousek I
Neoplasma; 1989; 36(1):103-12. PubMed ID: 2495492
[TBL] [Abstract][Full Text] [Related]
17. Retinyl substituted-benzyl ethers. Inhibition of mammary carcinogenesis by retinyl 3,4,5-trimethoxybenzyl ether (RTMBE).
Shealy YF; Frye JL; Hill DL; Sani BP; Rogers TS; Riordan JM; Krauth CA; Lin TH; Eto I; Grubbs CJ
Anticancer Drug Des; 1998 Apr; 13(3):159-82. PubMed ID: 9595031
[TBL] [Abstract][Full Text] [Related]
18. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
Thun-Battersby S; Mevissen M; Löscher W
Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of benz[a]pyrene-induced mammary carcinogenesis by retinyl acetate.
McCormick DL; Burns FJ; Albert RE
J Natl Cancer Inst; 1981 Mar; 66(3):559-64. PubMed ID: 6970847
[TBL] [Abstract][Full Text] [Related]
20. Effect of the duration of retinyl acetate feeding on inhibition of 1-methyl-1-nitrosourea-induced mammary carcinogenesis in the rat.
Thompson HJ; Becci PJ; Brown CC; Moon RC
Cancer Res; 1979 Oct; 39(10):3977-80. PubMed ID: 476636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
